SCHEMBL7239476

SCHEMBL7239476

O=C(C=CC(F)(F)CCCCN1CCOCC1)Oc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 15/20 0.57
ERBB2 P04626 8/20 0.53
AURKB Q96GD4 3/20 0.51
AURKA O14965 2/20 0.51
SRC P12931 2/20 0.46
KDR P35968 2/20 0.46
ROCK2 O75116 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LCK P06239 1/20 0.46
FYN P06241 1/20 0.46
RET P07949 1/20 0.46
MET P08581 1/20 0.46
MAPT P10636 1/20 0.46
PDGFRA P16234 1/20 0.46
LTK P29376 1/20 0.46
TTK P33981 1/20 0.46
MAP2K2 P36507 1/20 0.46
MAP2K1 Q02750 1/20 0.46
BTK Q06187 1/20 0.46
TYRO3 Q06418 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7241984 0.92 AURKA (0.49) EGFRERBB2AURKBAURKASRC
SCHEMBL7233932 0.91 EGFR (0.61) EGFRERBB2AURKBAURKASRC
SCHEMBL7235000 0.86 EGFR (0.56) EGFRERBB2AURKBAURKASRC
SCHEMBL7241596 0.85 EGFR (0.57) EGFRERBB2AURKBAURKASRC
SCHEMBL7127851 0.84 EGFR (0.47) EGFRERBB2AURKBSRCKDR
SCHEMBL7117656 0.84 EGFR (0.48) EGFRERBB2AURKBSRCKDR
SCHEMBL7121714 0.83 AURKB (0.43) EGFRERBB2AURKBAURKASRC
SCHEMBL7234306 0.83 EGFR (0.58) EGFRERBB2AURKBAURKASRC
SCHEMBL7242049 0.82 EGFR (0.61) EGFRERBB2AURKBAURKASRC
SCHEMBL7243134 0.81 EGFR (0.47) EGFRERBB2AURKBSRCKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127374-A AN ENZYME INHIBITOR FOR TREATING CANCER, RESTENOSIS, ATHEROSCLEROSIS, ENDOMETRIOSIS AND PSORIASIS WARNER-LAMBERT COMPANY (US) 2000-10-03 US claimed
WO-1999006378-A1 IRREVERSIBLE INHIBITORS OF TYROSINE KINASES WARNER-LAMBERT COMPANY (US) 1999-02-11 WO claimed
US-6562818-B1 For treating cancer, atherosclerosis, restenosis, endometriosis, and psoriasis WARNER-LAMBERT COMPANY 2003-05-13 US disclosed
US-6127374-A AN ENZYME INHIBITOR FOR TREATING CANCER, RESTENOSIS, ATHEROSCLEROSIS, ENDOMETRIOSIS AND PSORIASIS WARNER-LAMBERT COMPANY (US) 2000-10-03 US disclosed
WO-1999006378-A1 IRREVERSIBLE INHIBITORS OF TYROSINE KINASES WARNER-LAMBERT COMPANY (US) 1999-02-11 WO disclosed